ESR1 and depressive symptom measurement: However, when using depression scores at 34–36 weeks of gestation as predictors, higher depressive symptom scores were associated with a higher increase in ESR1 DNAm, potentially indicating sensitivity to epigenetic changes during the transition from pregnancy to postpartum in vulnerable women with elevated depressive symptoms during pregnancy.